ConductScience.org, home

Trial · NCT03087851

Results by group24

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Change in Lumbar Spine BMD From Baseline to 6 Months After the Zoledronic Acid Infusion.6-month Group-2.1Standard Error 0.9percentage change
Change in Lumbar Spine BMD From Baseline to 6 Months After the Zoledronic Acid Infusion.9-months Group-4.3Standard Error 1.1percentage change
Change in Lumbar Spine BMD From Baseline to 6 Months After the Zoledronic Acid Infusion.Observation Group-3.0Standard Error 1.1percentage change
Number of Participants Who Fail to Maintain BMD6-month Group10participants
Number of Participants Who Fail to Maintain BMD9-months Group5participants
Number of Participants Who Fail to Maintain BMDObservation Group6participants
Changes in BMD From Baseline to One Year After the Zoledronic Acid Infusion.6-month Group-4.8Standard Error 0.7percentage change
Changes in BMD From Baseline to One Year After the Zoledronic Acid Infusion.9-months Group-4.1Standard Error 1.1percentage change
Changes in BMD From Baseline to One Year After the Zoledronic Acid Infusion.Observation Group-4.7Standard Error 1.2percentage change
Changes in BMD From Baseline to Two Years After the Zoledronic Acid Infusion.6-month Group-4.0Standard Error 0.8percentage change
Changes in BMD From Baseline to Two Years After the Zoledronic Acid Infusion.9-months Group-4.1Standard Error 0.8percentage change
Changes in BMD From Baseline to Two Years After the Zoledronic Acid Infusion.Observation Group-4.3Standard Error 1.5percentage change
Changes in Cortical Porosity Measured by High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT) Scan at the Radius and Tibia From Baseline to One Year After the Zoledronic Acid Infusion.
6-month Group-2.5Standard Error 7.4percentage change
Changes in Cortical Porosity Measured by High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT) Scan at the Radius and Tibia From Baseline to One Year After the Zoledronic Acid Infusion.
9-months Group-1.6Standard Error 6.7percentage change
Changes in Cortical Porosity Measured by High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT) Scan at the Radius and Tibia From Baseline to One Year After the Zoledronic Acid Infusion.
Observation Group-4.2Standard Error 7.2percentage change
Changes in p-CTX From Baseline to Six Months After the Zoledronic Acid Infusion.6-month Group0.60Standard Deviation 0.35ug/l
Changes in p-CTX From Baseline to Six Months After the Zoledronic Acid Infusion.9-months Group0.47Standard Deviation 0.24ug/l
Changes in p-CTX From Baseline to Six Months After the Zoledronic Acid Infusion.Observation Group0.47Standard Deviation 0.20ug/l
Changes in p-CTX From Baseline to 12 Months After the Zoledronic Acid Infusion.6-month Group0.58Standard Deviation 0.23ug/l
Changes in p-CTX From Baseline to 12 Months After the Zoledronic Acid Infusion.9-months Group0.40Standard Deviation 0.20ug/l

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03087851/results